P04.49 Newborn affected by maternal use of other drugs of addiction

Name of the Condition

• Newborn affected by maternal use of other drugs of addiction
• ICD Code: P04.49

Summary

This condition describes health effects in a newborn resulting from maternal use of other drugs of addiction during pregnancy or breastfeeding. The newborn may exhibit signs or symptoms due to exposure to these substances, which can impact neonatal adaptation and health.

Causes

Maternal use of other drugs of addiction, such as non-opioid or non-stimulant substances, can cross the placenta and affect the fetus. Postnatally, substances in breast milk may also cause adverse effects in the newborn. The specific drugs and their timing of exposure influence the newborn's condition.

Risk Factors

• Maternal use of other drugs of addiction during pregnancy
• Lack of prenatal screening for substance use
• Breastfeeding while using harmful substances
• Prolonged or high-dose exposure to these agents
• Maternal health conditions related to substance use

Symptoms

Symptoms vary based on the substance and timing of exposure. Common signs include respiratory distress, poor feeding, lethargy, jitteriness, or withdrawal symptoms. Some newborns may exhibit growth restriction, neurodevelopmental issues, or congenital anomalies.

Diagnosis

Diagnosis involves a thorough maternal history review, including substance use details, newborn clinical assessment, and laboratory testing to detect drug exposure. Correlation with maternal history is critical for accurate diagnosis.

Treatment Options

Treatment focuses on managing neonatal symptoms, such as supportive care for withdrawal, respiratory support, and nutritional management. Long-term monitoring for developmental delays or other complications may be necessary.

Prognosis and Follow-Up

Prognosis depends on the substance, duration of exposure, and newborn response to treatment. Follow-up care includes monitoring for growth, neurodevelopmental progress, and addressing any long-term effects of exposure.

Complications

Potential complications include respiratory failure, seizures, growth restriction, neurodevelopmental delays, and increased risk of sudden infant death syndrome (SIDS).

Lifestyle & Prevention

Prevention involves maternal substance use cessation, prenatal care, and education on the risks of drug use during pregnancy and breastfeeding. Support for maternal recovery may reduce newborn exposure.

When to Seek Professional Help

Seek medical attention if the newborn exhibits respiratory distress, poor feeding, lethargy, jitteriness, or withdrawal symptoms. Prompt evaluation is critical for appropriate management.

Tips for Medical Coders

Document maternal substance use details, including the type of drug and timing of exposure, to support accurate coding. Ensure clinical correlation between maternal history and newborn symptoms when assigning P04.49.